T Petteri Piepponen Selected Research

Multiple Endocrine Neoplasia Type 2b (MEN 3)

1/2018	Constitutive Ret signaling leads to long-lasting expression of amphetamine-induced place conditioning via elevation of mesolimbic dopamine.
8/2011	Constitutive Ret signaling is protective for dopaminergic cell bodies but not for axonal terminals.
6/2008	Characterization of the striatal dopaminergic neurotransmission in MEN2B mice with elevated cerebral tissue dopamine.
5/2007	Constitutive Ret activity in knock-in multiple endocrine neoplasia type B mice induces profound elevation of brain dopamine concentration via enhanced synthesis and increases the number of TH-positive cells in the substantia nigra.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

T Petteri Piepponen Research Topics

Disease

7	Parkinson Disease (Parkinson's Disease) 06/2020 - 02/2009
4	Multiple Endocrine Neoplasia Type 2b (MEN 3) 01/2018 - 05/2007
2	Neoplasms (Cancer) 06/2020 - 05/2007
2	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2018 - 01/2017
1	Schizophrenia (Dementia Praecox) 08/2022
1	Psychotic Disorders (Schizoaffective Disorder) 08/2022
1	Brain Diseases (Brain Disorder) 08/2018
1	Mental Disorders (Mental Disorder) 01/2017
1	Prostatic Neoplasms (Prostate Cancer) 01/2014
1	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 05/2007

Drug/Important Bio-Agent (IBA)

8	Dopamine (Intropin)FDA LinkGeneric 08/2022 - 05/2007
6	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 08/2022 - 12/2015
4	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2019 - 05/2007
2	Nerve Growth Factors (Neurotrophins)IBA 08/2018 - 01/2018
2	Amphetamine (Amfetamine)FDA LinkGeneric 01/2018 - 08/2011
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2017 - 06/2008
2	Proteins (Proteins, Gene)FDA Link 02/2009 - 05/2007
1	Biological ProductsIBA 08/2018
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2018
1	alpha-SynucleinIBA 01/2018
1	lactacystinIBA 12/2015
1	Proteasome InhibitorsIBA 12/2015
1	prostatic acid phosphataseIBA 01/2014
1	NeurotoxinsIBA 08/2011
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 08/2011
1	Oxidopamine (6 Hydroxydopamine)IBA 08/2011
1	alpha-Methyltyrosine (Metirosine)FDA Link 06/2008
1	Tetrabenazine (Nitoman)FDA Link 06/2008
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2007
1	Cocaine (Cocaine HCl)IBA 05/2007
1	Messenger RNA (mRNA)IBA 05/2007

Therapy/Procedure

1	Therapeutics 08/2018
1	Deep Brain Stimulation 01/2018